Skip to main content

Inpharmatica Licenses Biopendium to Japan s Riken Center

NEW YORK, July 17 - Inpharmatica has sold a non-exclusive license to its Biopendium proteome-annotation tool to Japanese structural genomics center Riken, the company said today.

Inpharmatica's Tokyo-based partner PharmaDesign will provide Riken with primary training and support over the period of the subscription.
 
Financial terms of the agreement were not disclosed.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.